Moreover, the DNA alteration of these CRGs was observed in in OC, CESC, and UCEC patients based on the cBioProtal database (Supplementary Fig. 1), which partially explains the dysregulation of CRG in gynecologic tumors. This evidence concerns the gene CHD7 and female reproductive system neoplasm.